Ozempic Half-Life: How Long It Stays in Your System

Ozempic at a glance:

• Drug class: GLP-1 receptor agonist
• Manufacturer: Novo Nordisk
• FDA approved: 2017
• Route: subcutaneous injection (multi-dose pen)
• Typical frequency: once weekly
• Half-life: approximately 7 days (allows once-weekly dosing)
• Cash price (US): $950-$1,000/month without insurance
• Receptor target: GLP-1 receptor

The half-life of Ozempic (approximately 7 days (allows once-weekly dosing)) is the single most important number for understanding why it's dosed the way it is. Below we unpack the practical implications.

Half-Life Defined

The half-life is the time it takes for the concentration of a drug in the bloodstream to fall by half. It governs how often a drug needs to be dosed to maintain therapeutic levels and how long the drug persists after the last dose.

For Ozempic, the half-life is approximately 7 days (allows once-weekly dosing). That number explains the once weekly dosing schedule.

Time to Steady State

After starting (or changing) a dose, drug levels reach a new "steady state" after about 5 half-lives.

For Ozempic: with a 5-7 day half-life, steady state at a new dose is reached around 4-5 weeks. That's why dose increases are spaced ~4 weeks apart in the standard titration schedule.

How Long Ozempic Stays in Your System

A common question: "if I stop Ozempic, how long does it stay in my body?"

The standard rule of thumb is that a drug is essentially cleared after 5 half-lives. For Ozempic: that's approximately 35 days. Effects on appetite, glucose, or other targets persist for a similar period before fully resolving.

For incretin agents specifically, the appetite-related effects fade over weeks after stopping.

Practical Implications

A long half-life:

• Allows less frequent dosing (better adherence)
• Smooths out peaks and troughs (often better tolerability)
• Means dose changes take longer to fully express
• Creates a longer "runway" if a dose is missed

A short half-life:

• Requires more frequent dosing
• Produces sharper concentration peaks (and matching side effects)
• Allows faster dose adjustments
• Provides faster clearance if stopped

Ozempic, with its long half-life, falls on the long end of this spectrum.

Half-Life and Missed Doses

If a dose is missed:

• Take the missed dose as soon as you remember if you're well within the dosing interval
• Skip it if you're closer to the next dose
• Never double up

The longer the half-life, the more forgiving the missed-dose window. For Ozempic, the missed-dose window is relatively forgiving.

Half-Life Across the Drug Class

Within the broader class of glp-1 receptor agonist, half-lives vary significantly. Daily agents (liraglutide) have shorter half-lives; weekly agents (semaglutide, dulaglutide, tirzepatide) have half-lives in the multi-day range. See our comparison pages for direct comparisons.

Bottom Line

The approximately 7 days (allows once-weekly dosing) half-life of Ozempic is what makes its once weekly schedule work. Shorter half-lives need more frequent dosing; longer ones offer more flexibility.

Frequently Asked Questions

Related Reading

• What Is Ozempic? Everything You Should Know Before Starting
• Is Ozempic Safe? An Honest Look at the Side-Effect Profile
• Ozempic Results: Realistic Expectations vs. Trial Headlines
• Ozempic Cost Explained: Monthly, Yearly, and How to Save
• Getting Ozempic Dosing Right: A Step-by-Step Walkthrough
• Ozempic Before and After: A Week-by-Week Realistic Timeline

Sources

• Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. NEJM 2021;384:989.
• Marso SP et al. Semaglutide and Cardiovascular Outcomes in Type 2 Diabetes (SUSTAIN-6). NEJM 2016;375:1834.
• Pi-Sunyer X et al. A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management (SCALE). NEJM 2015;373:11.

This page is informational only and is not medical advice.